Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
K-103-IP for acute pain from ankle sprain or strain
NCT02089425Phase 3Terminated
- Start
- Apr 2014
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of indomethacin in acute pain (2 arms). Primary endpoint: Sum of Pain Intensity Difference 0-72 Hours. Started Apr 2014; status: terminated.
02
Drugs
indomethacin
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT02089425.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02089425.